Researchers will investigate how diet influences a horse's gut bacteria (microbiome) and metabolism (metabolome) and impacts insulin, key information to understanding how to feed horses at risk for laminitis.
Researchers will investigate if vaccinating mares will protect their newborn foals against pneumonia caused by the bacterium Rhodococcus equi.
Researchers will determine the optimal intravenous and intra-articular dosing protocol for amikacin, an antibiotic used to treat bacterial infections in foals.
Researchers will investigate a new laboratory test to improve diagnosis of equine metabolic syndrome, a metabolic and hormonal disorder in horses.
Researchers will use molecular methods to identify which species of equine parasitic worms come back first after deworming.
Researchers will investigate the potential relation between the bacterial composition of the gut, known as the microbiome, and the development of equine metabolic syndrome in Shetland ponies.
Researchers will evaluate genes associated with squamous cell carcinoma – a common cancer in horses affecting the eye area – to gauge their value as new therapeutic targets and their use in early cancer detection.
